Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Halpin

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
Archivos De Bronconeumologia|February 2, 2026
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
American Journal of Respiratory and Critical Care Medicine|November 4, 2020
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary DiseaseDavid M G Halpin, Gerard J Criner, Alberto Papi, et al.
ERJ Open Research|November 14, 2019
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study designSally Worsley, Neil Snowise, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2026
Defining disease stability in COPD: Evidence from Phase 3 clinical trialsDave Singh, Rianne Stacey, David M G Halpin, et al.
The European Respiratory Journal|February 26, 2026
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPDDavid M G Halpin, Sanja Stanojevic, Meredith C McCormack, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV<sub>1</sub>David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Respiratory Research|December 21, 2024
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for cliniciansKatrin Haeussler, Afisi S Ismaila, Mia Malmenäs, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|July 28, 2012
Frequency of non-asthma GP visits predicts asthma exacerbations: an observational study in general practiceMichael E Hyland, Ben Whalley, David M G Halpin, et al.
Clinical Endocrinology|January 16, 2008
A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in menAkheel A Syed, Christina G Halpin, Julie A E Irving, et al.
ERJ Open Research|May 12, 2018
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analysesDavid M G Halpin, Ruby Birk, Noushin Brealey, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
Archivos De Bronconeumologia|February 2, 2026
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
American Journal of Respiratory and Critical Care Medicine|November 4, 2020
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary DiseaseDavid M G Halpin, Gerard J Criner, Alberto Papi, et al.
ERJ Open Research|November 14, 2019
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study designSally Worsley, Neil Snowise, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2026
Defining disease stability in COPD: Evidence from Phase 3 clinical trialsDave Singh, Rianne Stacey, David M G Halpin, et al.
The European Respiratory Journal|February 26, 2026
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPDDavid M G Halpin, Sanja Stanojevic, Meredith C McCormack, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV<sub>1</sub>David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Respiratory Research|December 21, 2024
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for cliniciansKatrin Haeussler, Afisi S Ismaila, Mia Malmenäs, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|July 28, 2012
Frequency of non-asthma GP visits predicts asthma exacerbations: an observational study in general practiceMichael E Hyland, Ben Whalley, David M G Halpin, et al.
Clinical Endocrinology|January 16, 2008
A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in menAkheel A Syed, Christina G Halpin, Julie A E Irving, et al.
ERJ Open Research|May 12, 2018
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analysesDavid M G Halpin, Ruby Birk, Noushin Brealey, et al.
Pageof 20